Deutetrabenazine
RxNorm 1876905
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1876905 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: deutetrabenazine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Deutetrabenazine
(Atom ID: 8742975)
PTPrescribable
Designated preferred name (PT):
Deutetrabenazine
(Atom ID: 9249921)
FNPrescribable
Full form of descriptor (FN):
Deutetrabenazine (substance)
(Atom ID: 9249922)
PTPrescribable
Designated preferred name (PT):
Deutetrabenazine-containing product
(Atom ID: 10800962)
FNPrescribable
Full form of descriptor (FN):
Product containing deutetrabenazine (medicinal product)
(Atom ID: 10305856)
Patient Education
Deutetrabenazine
Deutetrabenazine is used to treat chorea (sudden movements that you cannot control) caused by Huntington's disease (an inherited disease that causes the progressive breakdown of nerve cells in the brain). It is also used to treat tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts). Deutetrabenazine is in a class of medications called vesicular monoamine transporter 2 (VMAT2) inhibitors. It works by changing the activity of certain natural substances in the brain that affect nerves and muscles.
[Learn More]
* Please review the disclaimer below.